vs

Side-by-side financial comparison of American Express (AXP) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.

American Express is the larger business by last-quarter revenue ($18.9M vs $16.2M, roughly 1.2× SurgePays, Inc.). American Express runs the higher net margin — 15.7% vs -85.6%, a 101.4% gap on every dollar of revenue. On growth, SurgePays, Inc. posted the faster year-over-year revenue change (68.7% vs 11.4%). Over the past eight quarters, SurgePays, Inc.'s revenue compounded faster (-28.2% CAGR vs -95.6%).

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products an...

SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.

AXP vs SURG — Head-to-Head

Bigger by revenue
AXP
AXP
1.2× larger
AXP
$18.9M
$16.2M
SURG
Growing faster (revenue YoY)
SURG
SURG
+57.2% gap
SURG
68.7%
11.4%
AXP
Higher net margin
AXP
AXP
101.4% more per $
AXP
15.7%
-85.6%
SURG
Faster 2-yr revenue CAGR
SURG
SURG
Annualised
SURG
-28.2%
-95.6%
AXP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AXP
AXP
SURG
SURG
Revenue
$18.9M
$16.2M
Net Profit
$3.0M
$-13.9M
Gross Margin
-14.8%
Operating Margin
-79.1%
Net Margin
15.7%
-85.6%
Revenue YoY
11.4%
68.7%
Net Profit YoY
15.0%
30.0%
EPS (diluted)
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXP
AXP
SURG
SURG
Q1 26
$18.9M
Q4 25
$10.9B
$16.2M
Q3 25
$10.4B
$18.7M
Q2 25
$10.3B
$11.5M
Q1 25
$9.6B
$10.6M
Q4 24
$10.0B
$9.6M
Q3 24
$9.7B
$4.8M
Q2 24
$9.8B
$15.1M
Net Profit
AXP
AXP
SURG
SURG
Q1 26
$3.0M
Q4 25
$2.5B
$-13.9M
Q3 25
$2.9B
$-7.5M
Q2 25
$2.9B
$-7.1M
Q1 25
$2.6B
$-7.6M
Q4 24
$2.2B
$-19.8M
Q3 24
$2.5B
$-14.3M
Q2 24
$3.0B
$-12.9M
Gross Margin
AXP
AXP
SURG
SURG
Q1 26
Q4 25
-14.8%
Q3 25
-13.9%
Q2 25
-23.0%
Q1 25
-27.8%
Q4 24
-117.0%
Q3 24
-164.2%
Q2 24
-22.8%
Operating Margin
AXP
AXP
SURG
SURG
Q1 26
Q4 25
28.2%
-79.1%
Q3 25
36.7%
-37.2%
Q2 25
34.4%
-59.1%
Q1 25
34.6%
-71.7%
Q4 24
27.7%
-209.0%
Q3 24
33.0%
-299.4%
Q2 24
38.6%
-72.1%
Net Margin
AXP
AXP
SURG
SURG
Q1 26
15.7%
Q4 25
22.5%
-85.6%
Q3 25
27.9%
-40.1%
Q2 25
28.0%
-61.5%
Q1 25
26.8%
-72.2%
Q4 24
21.8%
-206.5%
Q3 24
25.8%
-299.3%
Q2 24
30.7%
-85.3%
EPS (diluted)
AXP
AXP
SURG
SURG
Q1 26
Q4 25
$3.52
$-0.68
Q3 25
$4.14
$-0.38
Q2 25
$4.08
$-0.36
Q1 25
$3.64
$-0.38
Q4 24
$3.04
$-1.07
Q3 24
$3.49
$-0.73
Q2 24
$4.15
$-0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXP
AXP
SURG
SURG
Cash + ST InvestmentsLiquidity on hand
$1.7M
Total DebtLower is stronger
$60.4M
$13.3M
Stockholders' EquityBook value
$34.0M
$-15.3M
Total Assets
$308.9M
$8.5M
Debt / EquityLower = less leverage
1.78×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXP
AXP
SURG
SURG
Q1 26
Q4 25
$742.0M
$1.7M
Q3 25
$1.3B
$2.5M
Q2 25
$197.0M
$4.4M
Q1 25
$261.0M
$5.4M
Q4 24
$221.0M
$11.8M
Q3 24
$120.0M
$23.7M
Q2 24
$188.0M
Total Debt
AXP
AXP
SURG
SURG
Q1 26
$60.4M
Q4 25
$56.4B
$13.3M
Q3 25
$57.8B
$12.0M
Q2 25
$58.2B
$9.6M
Q1 25
$51.2B
$3.6M
Q4 24
$49.7B
$4.0M
Q3 24
$53.5B
$4.4M
Q2 24
$51.5B
$4.8M
Stockholders' Equity
AXP
AXP
SURG
SURG
Q1 26
$34.0M
Q4 25
$33.5B
$-15.3M
Q3 25
$32.4B
$-6.4M
Q2 25
$32.3B
$116.1K
Q1 25
$31.2B
$7.8M
Q4 24
$30.3B
$15.3M
Q3 24
$29.7B
$33.2M
Q2 24
$29.5B
$46.2M
Total Assets
AXP
AXP
SURG
SURG
Q1 26
$308.9M
Q4 25
$300.1B
$8.5M
Q3 25
$297.6B
$14.5M
Q2 25
$295.6B
$15.2M
Q1 25
$282.2B
$15.7M
Q4 24
$271.5B
$24.0M
Q3 24
$271.0B
$41.5M
Q2 24
$272.2B
$56.4M
Debt / Equity
AXP
AXP
SURG
SURG
Q1 26
1.78×
Q4 25
1.68×
Q3 25
1.78×
Q2 25
1.80×
82.67×
Q1 25
1.64×
0.46×
Q4 24
1.64×
0.26×
Q3 24
1.80×
0.13×
Q2 24
1.74×
0.10×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXP
AXP
SURG
SURG
Operating Cash FlowLast quarter
$-3.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXP
AXP
SURG
SURG
Q1 26
Q4 25
$3.1B
$-3.6M
Q3 25
$6.2B
$-4.6M
Q2 25
$4.4B
$-6.1M
Q1 25
$4.8B
$-7.0M
Q4 24
$5.8B
$-7.9M
Q3 24
$-1.8B
$-13.3M
Q2 24
$4.5B
$-4.1M
Free Cash Flow
AXP
AXP
SURG
SURG
Q1 26
Q4 25
$2.3B
Q3 25
$5.6B
Q2 25
$3.7B
Q1 25
$4.3B
Q4 24
$5.3B
Q3 24
$-2.3B
Q2 24
$4.0B
FCF Margin
AXP
AXP
SURG
SURG
Q1 26
Q4 25
21.4%
Q3 25
53.6%
Q2 25
36.3%
Q1 25
45.0%
Q4 24
53.1%
Q3 24
-23.3%
Q2 24
40.4%
Capex Intensity
AXP
AXP
SURG
SURG
Q1 26
Q4 25
6.6%
Q3 25
6.3%
Q2 25
6.0%
Q1 25
4.5%
Q4 24
5.0%
Q3 24
4.7%
Q2 24
5.8%
Cash Conversion
AXP
AXP
SURG
SURG
Q1 26
Q4 25
1.25×
Q3 25
2.15×
Q2 25
1.51×
Q1 25
1.84×
Q4 24
2.66×
Q3 24
-0.72×
Q2 24
1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXP
AXP

Discount revenue$9.5M50%
Other$8.9M47%
Deposits with banks and other$512.0K3%

SURG
SURG

Segment breakdown not available.

Related Comparisons